Western University Launches Initiative for Global HIV Cure Access

Western University has initiated a groundbreaking international collaboration called IMMUNEQUITY aimed at ensuring equitable access to a potential cure for HIV. Led by prominent researchers including Eric Arts, Canada Research Chair in HIV Pathogenesis, the initiative seeks to transform how HIV treatments are developed, prioritizing accessibility from the outset.

The urgency of this mission is underscored by stark disparities in healthcare access. Although advancements in HIV treatment have been remarkable, with antiretroviral therapy turning HIV into a manageable condition, millions in low-income regions, particularly in sub-Saharan Africa, still await innovations that are readily available in wealthier countries. “Where you live still determines whether you benefit from medical breakthroughs,” stated Arts, emphasizing the need for a more equitable approach.

Revolutionizing HIV Treatment Development

IMMUNEQUITY brings together a diverse team from various institutions, including Maria Drangova and David Holdsworth from medical biophysics, as well as engineering and law experts from Western University and partners in Uganda, such as the Joint Clinical Research Centre (JCRC) and Makerere University. Their collective goal is to integrate scientific innovation with affordability and global accessibility, creating a model that could redefine future biomedical advancements.

Currently, the only established cure for HIV involves an intensive and costly procedure known as hematopoietic stem cell transplantation (HSCT). This method, which requires significant resources and infrastructure, can cost over $350,000 per patient, making it unattainable for many. The team behind IMMUNEQUITY aims to reverse the conventional development process by designing therapies that are manufacturable and affordable for low- and middle-income countries from the very beginning.

The scientific strategy at the heart of IMMUNEQUITY focuses on a method called ‘kick and kill.’ This approach activates dormant HIV-infected cells, making them vulnerable to targeted therapies. Rather than relying on expensive chemotherapies, Arts and his colleagues will explore the use of biologics—precision immunotherapies tailored to effectively target HIV.

Community-Centric Approach to HIV Solutions

Recognizing the importance of local context, the initiative will actively involve individuals living with HIV in both Canada and Uganda. The team will ensure that legal, social, and ethical considerations inform the project throughout its development. Bassem Awad, a law professor involved in the initiative, is designing an intellectual property strategy to prevent legal barriers from hindering access to new treatments.

Through this collaborative model, the researchers aim not only to develop an HIV cure but also to create a framework for future biomedical innovations that prioritize community engagement and equitable access. Brian Lubega, a laboratory technologist at JCRC, underscores the importance of co-development, stating that community voices will shape every aspect of the initiative, from planning to clinical trials.

With approximately 40 million people living with HIV globally, the potential impact of an accessible cure is immense. Current annual treatment costs vary significantly, with low-income countries facing expenses of around US$1,000 per person for generic treatments, while costs in high-income countries can exceed $30,000.

By addressing these disparities, IMMUNEQUITY not only seeks to enhance healthcare access but also aims to strengthen the economic landscape of biomanufacturing in both Uganda and Canada. This initiative represents a significant step toward closing the gap between scientific discovery and practical accessibility.

As Arts aptly puts it, “The best cure in the world is meaningless if it cannot be produced at a large scale and affordable cost in resource-limited settings.” With the foundation of IMMUNEQUITY, the researchers are poised to pave the way for a new era in HIV treatment that prioritizes equity and accessibility, potentially setting a precedent for tackling other global health challenges in the future.